Vaccine Hesitancy among Parents and Its Association with the Uptake of Measles Vaccine in Urban Settings in Khartoum State, Sudan [PDF]
Vaccine uptake is one of the indicators that has been used to guide immunization programs. This study aimed to evaluate whether measles vaccine uptake is predicted by measles vaccine hesitancy.
Mohamed Moukhyer +2 more
exaly +4 more sources
Laboratory response to an infant with suspected measles vaccine associated fever and rash in Sri Lanka [PDF]
Background: Measles is a highly contagious illness. Sri Lanka (SL) has eliminated the measles in 2019. The country is at risk of importation of measles and there could be vaccine-associated measles like illnesses.
Buddhini Samaraweera +5 more
doaj +2 more sources
Perceived Vaccine Availability and the Uptake of Measles Vaccine in Sudan: The Mediating Role of Vaccination Hesitancy [PDF]
This study aimed to evaluate whether measles vaccine uptake can be predicted directly or indirectly by parental perceptions about the availability of measles vaccine services with parental hesitancy towards the measles vaccine as a potential mediator ...
Majdi M. Sabahelzain +3 more
doaj +2 more sources
Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy [PDF]
Background Malaysia introduced the two dose measles-mumps-rubella (MMR) vaccine in 2004 as part of its measles elimination strategy. However, despite high historical coverage of MCV1 and MCV2, Malaysia continues to report high measles incidence.
Shurendar Selva Kumar +4 more
doaj +3 more sources
Determinants of Measles Vaccine Hesitancy among Sudanese Parents in Khartoum State, Sudan: A Cross-Sectional Study [PDF]
Determinants of vaccine hesitancy are not yet well understood. This study aims to assess measles vaccine hesitancy and characterize its determinants among Sudanese parents in Omdurman in Khartoum State.
Majdi M. Sabahelzain +3 more
doaj +2 more sources
Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was developed empirically by attenuation of wild-type (WT) MeV by in vitro passage in human and chicken cells and licensed in 1963.
Diane Griffin
exaly +3 more sources
Construction and Preclinical Evaluation of a Recombinant Attenuated Measles Vaccine Candidate of the H1a Genotype [PDF]
Background: Measles, an acute respiratory infectious disease caused by the measles virus, continues to pose a significant threat to children under five years old worldwide.
Lixia Xie +12 more
doaj +2 more sources
Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era [PDF]
The COVID-19 pandemic has severely affected health systems worldwide and raised the issue of vaccine hesitancy. In 2022, the World Health Organization reported an outbreak of measles infection among people over 20 years of age in the European Region ...
Cristiana Ferrari +10 more
doaj +2 more sources
Measles and Measles Vaccine in Japan [PDF]
Before the introduction of measles vaccine in 1971, measles was a common and well-recognized disease in Japanese children. Seroepidemiological studies conducted before the general use of the vaccine disclosed that measles epidemics differed from community to community; in rural areas, epidemics appeared at intervals of several years with the ...
ISOMURA, SHIN
openaire +4 more sources
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria [PDF]
Nigeria has the highest burden of measles worldwide, as measles vaccine uptake remains low. Recently, the second dose of the measles-containing vaccine (MCV2) was introduced as part of the routine immunization (RI) program, and this study examined how it
Ryoko Sato
doaj +2 more sources

